References
- Wahab NN, Cowden EA, Pearce NJ, et al. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol. 2002;40(10):1748–1754. doi:10.1016/S0735-1097(02)02483-X
- Kim JA, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation. 2006;113(15):1888–1904. doi:10.1161/CIRCULATIONAHA.105.563213
- Zeller M, Steg PG, Ravisy J, et al. Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction. Arch Intern Med. 2005;165(10):1192–1198. doi:10.1001/archinte.165.10.1192
- Kosiborod M, Inzucchi SE, Krumholz HM, et al. Glucose normalization and outcomes in patients with acute myocardial infarction. Arch Intern Med. 2009;169(5):438–446. doi:10.1001/archinternmed.2008.593
- Rastaldo R, Pagliaro P, Cappello S, et al. Nitric oxide and cardiac function. Life Sci. 2007;81(10):779–793. doi:10.1016/j.lfs.2007.07.019
- Roy D, Perreault M, Marette A. Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent. Am J Physiol. 1998;274(4):E692–699. doi:10.1152/ajpendo.1998.274.4.E692
- Duplain H, Burcelin R, Sartori C, et al. Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation. 2001;104(3):342–345. doi:10.1161/01.CIR.104.3.342
- Shankar RR, Wu Y, Shen HQ, Zhu JS, Baron AD. Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. Diabetes. 2000;49(5):684–687. doi:10.2337/diabetes.49.5.684
- Gilligan DM, Guetta V, Panza JA, Garcia CE, Quyyumi AA, Cannon RO 3rd. Selective loss of microvascular endothelial function in human hypercholesterolemia. Circulation. 1994;90(1):35–41. doi:10.1161/01.CIR.90.1.35
- Zeiher AM, Drexler H, Wollschlager H, Just H. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. 1991;83(2):391–401. doi:10.1161/01.CIR.83.2.391
- Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest. 1996;97(11):2601–2610. doi:10.1172/JCI118709
- Ferreira AP, Ferreira CB, Souza VC, et al. Risk of glycemic disorder in elderly women adjusted by anthropometric parameters and cytokine genotypes. Rev Assoc Med Bras. 2011;57(5):565–569. doi:10.1590/S0104-42302011000500016
- Alharbi KK, Abudawood M, Khan IA. Amino-acid amendment of arginine-325-tryptophan in rs13266634 genetic polymorphism studies of the SLC30A8 gene with type 2 diabetes-mellitus patients featuring a positive family history in the Saudi population. J King Saud Univ Sci. 2021;33(1):101258. doi:10.1016/j.jksus.2020.101258
- Zhang YH, Jin CZ, Jang JH, Wang Y. Molecular mechanisms of neuronal nitric oxide synthase in cardiac function and pathophysiology. J Physiol. 2014;592(15):3189–3200. doi:10.1113/jphysiol.2013.270306
- Saur D, Vanderwinden JM, Seidler B, Schmid RM, De Laet MH, Allescher HD. Single-nucleotide promoter polymorphism alters transcription of neuronal nitric oxide synthase exon 1c in infantile hypertrophic pyloric stenosis. Proc Natl Acad Sci U S A. 2004;101(6):1662–1667. doi:10.1073/pnas.0305473101
- Cui H, Nishiguchi N, Yanagi M, et al. A putative cis-acting polymorphism in the NOS1 gene is associated with schizophrenia and NOS1 immunoreactivity in the postmortem brain. Schizophr Res. 2010;121(1–3):172–178. doi:10.1016/j.schres.2010.05.003
- Machado-Silva W, Alfinito-Kreis R, Carvalho LS, et al. Endothelial nitric oxide synthase genotypes modulate peripheral vasodilatory properties after myocardial infarction. Gene. 2015;568(2):165–169. doi:10.1016/j.gene.2015.05.042
- Caumo A, Perseghin G, Brunani A, Luzi L. New insights on the simultaneous assessment of insulin sensitivity and beta-cell function with the HOMA2 method. Diabetes Care. 2006;29(12):2733–2734. doi:10.2337/dc06-0070
- Reif A, Herterich S, Strobel A, et al. A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Mol Psychiatry. 2006;11(3):286–300. doi:10.1038/sj.mp.4001779
- Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39(2):257–265. doi:10.1016/S0735-1097(01)01746-6
- Kahn SE, Prigeon RL, McCulloch DK, et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes. 1993;42(11):1663–1672. doi:10.2337/diab.42.11.1663
- Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest. 1994;94(3):1172–1179. doi:10.1172/JCI117433
- Forstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J. 2012;33(7):829–837, 837a–837d. doi:10.1093/eurheartj/ehr304
- Kashyap SR, Roman LJ, Lamont J, et al. Insulin resistance is associated with impaired nitric oxide synthase activity in skeletal muscle of type 2 diabetic subjects. J Clin Endocrinol Metab. 2005;90(2):1100–1105. doi:10.1210/jc.2004-0745
- Turini P, Thalmann S, Jayet PY, et al. Insulin resistance in mice lacking neuronal nitric oxide synthase is related to an alpha-adrenergic mechanism. Swiss Med Wkly. 2007;137(49–50):700–704.
- Lu QB, Feng XM, Tong N, et al. Neuronal and endothelial nitric oxide synthases in the paraventricular nucleus modulate sympathetic overdrive in insulin-resistant rats. PLoS One. 2015;10(10):e0140762. doi:10.1371/journal.pone.0140762
- Esler M, Rumantir M, Wiesner G, Kaye D, Hastings J, Lambert G. Sympathetic nervous system and insulin resistance: from obesity to diabetes. Am J Hypertens. 2001;14(11 Pt 2):304S–309S. doi:10.1016/S0895-7061(01)02236-1
- Guazzi M, Reina G, Gripari P, Tumminello G, Vicenzi M, Arena R. Prognostic value of flow-mediated dilatation following myocardial infarction. Int J Cardiol. 2009;132(1):45–50. doi:10.1016/j.ijcard.2007.10.036
- Kannenkeril D, Bosch A, Kolwelter J, et al. Dependency of flow-mediated vasodilatation from basal nitric oxide activity. Clin Physiol Funct Imaging. 2021;41(4):310–316. doi:10.1111/cpf.12696